| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $50.2M | +6.0% | +11.4% |
| Cost of Revenue | $10.5M | +9.1% | +17.4% |
| Gross Profit | $39.7M | +5.2% | +9.9% |
| R&D Expense | $4.7M | -14.9% | -5.7% |
| SG&A Expense | $16.3M | +0.8% | +20.4% |
| Operating Income | -$15.7M | +7.6% | -3.6% |
| Interest Expense | $1.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.7M | -4.5% | -36.5% |
| Short-term Investments | $49.7M | -18.8% | -29.6% |
| Accounts Receivable | $33.0M | +8.7% | +36.3% |
| Inventory | $41.4M | -2.3% | -5.0% |
| Current Assets | $138.0M | -6.5% | -12.4% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.9M | — | — |
| Capital Expenditures | $11.1M | — | — |
| Investing Cash Flow | $3.6M | — | — |
| Financing Cash Flow | $695K | — | — |
| Free Cash Flow | -$19.1M | — | — |
| +1.3% |
| +1.9% |
| Net Income | -$16.3M | +6.4% | -6.0% |
| EPS (Basic) | -$0.26 | +7.1% | -4.0% |
| EPS (Diluted) | -$0.26 | +7.1% | -4.0% |
| $196.6M |
| -4.8% |
| -7.7% |
| Current Liabilities | $40.9M | -2.4% | +6.9% |
| Long-term Debt | $53.5M | +0.1% | +0.6% |
| Total Liabilities | $107.4M | -1.3% | -0.6% |
| Stockholders' Equity | $89.2M | -8.6% | -15.0% |